New Zealand has advance purchased two new coronavirus vaccines from pharmaceutical companies AstraZeneca and Novavax, giving the small island country the ability to vaccinate its 5 million residents.
Government officials also announced Thursday they will go a step further and provide free doses to its population as well as neighboring nations Tokelau, Cook Islands, Niue, Samoa, Tonga, and Tuvalu, should they want them.
Prime Minister Jacinda Ardern said during a news conference that the effort would be the country's largest immunization rollout ever.
"Never before has the entire globe sought to vaccinate the entire population at the same time," Ardern said. "This will be a sustained rollout over months not weeks but our pre-purchase agreements means New Zealand is well positioned to get on with it as soon as it is proven safe to do so."
The University of Oxford-AstraZeneca and Novavax vaccines will add to New Zealand's previously agreed upon purchases of vaccines from Pfizer-BioNTech and Janssen Pharmaceutica. The new agreements secures access to 7.6 million doses from AstraZeneca – enough for 3.8 million people, and 10.72 million doses from Novavax– enough for 5.36 million people, according to the government. Both vaccines require two doses.